bcli has low institutional and low cash ...it won't go up...trust me...this company needs money to run the trial...they don't care about shareholders..they will do the dilution all the time to raise money
A. If this works in people it may be a better fit for their technology than ALS. A nagging doubt about ALS is the cost and feasability of producing enough cells to stay ahead of the disease. Improvement from a single treatment would be more likely to last with autism since it is not progressively degenerative.
B. the mice are abnormal in the same regions where autistic people are abnormal but it is speculation that this is actually treating the same thing.
C. This at least is more validation that the treatment can improve serious damage of some sort. If this works then why not stroke for example?
D. I am skeptical that they pushed this forward before releasing anything more on MS or Parkinson's.
I am long BCLI but not nearly as much as I used to be.
investing in a stock that has low cash...dilution will be 100%...they don't care about shareholders..they care only MONEY MONEY so it can help them fund for the trial
still years out but at this price why not throw some shares in the corner?
e=mc2 was also low cash in the beginning all great things start with just an idea, so what is your point !
If what BCLI is workig on proves to be for real; and it looks increasingly like it will. YOU AIN'T SEEN NOTHING YET. THE SKY IS THE LIMIT. PEACE TO ALL...
Sentiment: Strong Buy
it does not matter..they have low cash.....they need money to run the trial....u will understand later on why BCLI keeps going down
The 1st human implant was done 90 days ago in Arizona.'
The patient is now recovering and you can see his youtube videos of him moving his legs, walking in the therapy pool and crawling in his room, using his legs.'
This is the biggest news in medicine yet many investors are just finding out.
Do your DD.
The inventor, Dr. Bob Langer, is expected to receive the Nobel Prize for medicine for this dramatic advance.
He has won every other major award over the last 3 decades.
1. The company has low cash
2. The company has low institutional ownership
They are likely to do the dilution all the time. That's why if you want to invest in a good company...pick the one that has huge cash + high institiutional onwership...this stock is only good to short..don't keep it for too long..it will go under 1 buck soon....
If BCLI is able to prove an effect on Autism, the market for it will be astronomical. Rates of Autism keep rising and no one knows why. Treatment options are limited and good effective treatment is a huge unmet need.
I should clarify that I do believe they are doing some great work and possibly have a very valid treatment. It's just that I believe the way they went about the PR and then exercising warrants was a little shady and left the retailers holding the bag. I guess you have to do whats necessary to fund a venture.
I believe this is what you get with a biotech that has aligned themselves with a hedgefund. Perfect timing for pump and dumps. Is this company a scam with it's treatment? It could be very legit, but be very careful putting real money in this due to the serious manipulation that will be going on here in the years to come.
The next real results are for april 2016. Better let i sleep 'til then. Or take the opportunity to average down as much as possible if it goes lower.